A detailed history of Hilltop Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hilltop Partners LLC holds 1,246 shares of LLY stock, worth $929,765. This represents 0.37% of its overall portfolio holdings.

Number of Shares
1,246
Previous 1,183 5.33%
Holding current value
$929,765
Previous $1.07 Billion 3.1%
% of portfolio
0.37%
Previous 0.4%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $48,644 - $60,481
63 Added 5.33%
1,246 $1.1 Billion
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $150,772 - $189,080
208 Added 21.33%
1,183 $1.07 Billion
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $42,046 - $56,251
71 Added 7.85%
975 $758 Million
Q4 2023

Feb 15, 2024

BUY
$525.19 - $619.13 $219,529 - $258,796
418 Added 86.01%
904 $527 Million
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $6,520 - $8,989
15 Added 3.18%
486 $261 Million
Q2 2023

Aug 02, 2023

BUY
$350.74 - $468.98 $165,198 - $220,889
471 New
471 $221 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hilltop Partners LLC Portfolio

Follow Hilltop Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hilltop Partners LLC with notifications on news.